Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
8.555 USD | +0.88% | -3.42% | +0.36% |
12:33pm | Wedbush Adjusts Voyager Therapeutics' PT to $8 From $10, Keeps Neutral Rating | MT |
05-13 | Transcript : Voyager Therapeutics, Inc., Q1 2024 Earnings Call, May 13, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+0.36% | 461M | |
+27.43% | 48.16B | |
-1.00% | 41.73B | |
+43.45% | 41.03B | |
-5.26% | 28.77B | |
+10.14% | 25.59B | |
-22.97% | 18.96B | |
+7.90% | 12.92B | |
+29.11% | 12.03B | |
-2.22% | 11.77B |
- Stock Market
- Equities
- VYGR Stock
- News Voyager Therapeutics, Inc.
- Voyager Therapeutics : Wedbush Adjusts Voyager Therapeutics' PT to $3 From $6, Citing Profit Share Arrangement, Potential Secondary Offering Size; Neutral Rating Kept